EZH2 Inhibition Compromises α4-1BB-Mediated Antitumor Efficacy by Reducing the Survival and Effector Programming of CD8+ T Cells

By
Justin.choi
-
0
21
The authors explored the combination between zeste homolog 2 (EZH2) inhibitor and an agonist antibody targeting the T cell costimulatory receptor 4-1BB.
[Frontiers in Immunology]

Sorry, but the selected Zotpress account can't be found.

Full Article